Methoxy polyethylene glycol-epoetin beta
- Generic Name
- Methoxy polyethylene glycol-epoetin beta
- Brand Names
- Mircera
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 677324-53-7
- Unique Ingredient Identifier
- LR3UXN0193
- Background
Methoxy polyethylene glycol-epoetin beta is a chemically synthesised Erythropoiesis Stimulating Agent (ESA) with a longer half-life than erythropoietin. ESA is used to increase synthesis of red blood cells to treat chronic kidney disease associated anemia.
- Indication
For the treatment of patients with anaemia associated with chronic kidney disease. Not a substitute for RBC transfusion if immediate correction of anemia is required.
- Associated Conditions
- Anemia
- Associated Therapies
- -
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.
- Conditions
- Anemia
- Interventions
- First Posted Date
- 2008-07-18
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 421
- Registration Number
- NCT00717821
Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis
- First Posted Date
- 2008-07-17
- Last Posted Date
- 2017-09-08
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 64
- Registration Number
- NCT00717366
- Locations
- 🇪🇸
Hospital Universitario La Paz: Nefrologia Pediatrica, Madrid, Spain
🇮🇹IRCCS G. Gaslini; U.O. Nefrologia, Dialisi e Trapianto, Genova, Liguria, Italy
🇪🇸Hospital Universitario la Fe; Servicio de Nefrologia Pediatrica, Valencia, Spain
A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2017-12-06
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 132
- Registration Number
- NCT00661505
- Locations
- 🇹🇷
Adnan Menderes Uni School of Medicine; Physical Therapy & Rehabilitation, Aydin, Turkey
🇹🇷Trakya University Medical Faculty; Internal Medicine; Nephrology, Edirne, Turkey
🇹🇷Izmir Ataturk Research and Training Hospital; The Clinic of Nephrology, Izmir, Turkey
A Study of Intravenous Mircera in Participants With Chronic Renal Anemia Who Are on Dialysis
- First Posted Date
- 2008-04-17
- Last Posted Date
- 2016-03-15
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 124
- Registration Number
- NCT00660023
A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia
- First Posted Date
- 2008-03-25
- Last Posted Date
- 2017-07-05
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 35
- Registration Number
- NCT00642668
- Locations
- 🇧🇪
ZNA Stuivenberg, Antwerpen, Belgium
🇧🇪ZNA Middelheim, Antwerpen, Belgium
🇧🇪CH EpiCURA Site Hornu, Hornu, Belgium
A Study of Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis
- First Posted Date
- 2008-03-25
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 127
- Registration Number
- NCT00642967
A Study of Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal Anemia
- Conditions
- Anemia
- Interventions
- Drug: Epoetin alfaDrug: methoxy polyethylene glycol-epoetin beta
- First Posted Date
- 2008-01-31
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 101
- Registration Number
- NCT00605293
A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.
- First Posted Date
- 2007-11-19
- Last Posted Date
- 2016-08-24
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT00560547
A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis
- First Posted Date
- 2007-11-16
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 184
- Registration Number
- NCT00559637
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis
- Conditions
- Renal Anemia, Chronic
- Interventions
- First Posted Date
- 2007-11-16
- Last Posted Date
- 2016-11-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 307
- Registration Number
- NCT00559273
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.